Literature DB >> 8523582

Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.

W Paulus1, I Baur, F M Boyce, X O Breakefield, S A Reeves.   

Abstract

Retroviral vectors that contain the tetracycline-inducible (Tet) system were developed. The two components of the Tet system were organized within the vectors in a manner that stringently maintains tetracycline-dependent regulation. Regulated expression of an indicator gene inserted into the retroviral vectors was examined in several different cell types. In infected NIH 3T3 cells, levels of induction in the absence of tetracycline were observed to be as much as 336-fold higher than levels in the presence of tetracycline, which were extremely low. Tetracycline-dependent regulation was observed in all other transduced cell types and ranged from 24- to 127-fold. The generation of retroviral vectors containing regulatory elements that allow for the regulated expression of heterologous genes and that have the ability to infect virtually all dividing target cells should greatly facilitate the biochemical and genetic examination of a broad range of genes. Moreover, these inducible retroviral vectors should prove useful in gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523582      PMCID: PMC189788     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Tissue-specific expression of functionally rearranged lambda 1 Ig gene through a retrovirus vector.

Authors:  R D Cone; E B Reilly; H N Eisen; R C Mulligan
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

Review 3.  Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements.

Authors:  M Gossen; A L Bonin; H Bujard
Journal:  Trends Biochem Sci       Date:  1993-12       Impact factor: 13.807

4.  A survey of transformation markers in differentiating epidermal cell lines in culture.

Authors:  S H Yuspa; P Hawley-Nelson; B Koehler; J R Stanley
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

5.  Regulation of the host range of human papovavirus JCV.

Authors:  L Feigenbaum; K Khalili; E Major; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Tetracycline-regulated cardiac gene expression in vivo.

Authors:  G I Fishman; M L Kaplan; P M Buttrick
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Gene expression from transcriptionally disabled retroviral vectors.

Authors:  J K Yee; J C Moores; D J Jolly; J A Wolff; J G Respess; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain.

Authors:  J Henson; J Saffer; H Furneaux
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

9.  Retrovirus-mediated gene transfer of transthyretin and transthyretin-methionine 30: a potential tool for the study of amyloidogenesis.

Authors:  M J Bonifácio; D Ezzeddine; Y Sakaki; X O Breakfield; M J Saraiva
Journal:  Neuromuscul Disord       Date:  1993-07       Impact factor: 4.296

10.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  41 in total

Review 1.  Regulatable systems: applications in gene therapy and replicating viruses.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  An episomal vector for stable tetracycline-regulated gene expression.

Authors:  M Jost; C Kari; U Rodeck
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.

Authors:  Nicole R Bianco; Laura J Chaplin; Monica M Montano
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

Review 5.  Diverse strategies for tetracycline-regulated inducible gene expression.

Authors:  P E Shockett; D G Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

6.  Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.

Authors:  G Watanabe; C Albanese; R J Lee; A Reutens; G Vairo; B Henglein; R G Pestell
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

7.  Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo.

Authors:  D Lindemann; E Patriquin; S Feng; R C Mulligan
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

8.  A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system.

Authors:  J J Hwang; L Li; W F Anderson
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.

Authors:  R J Lee; C Albanese; M Fu; M D'Amico; B Lin; G Watanabe; G K Haines; P M Siegel; M C Hung; Y Yarden; J M Horowitz; W J Muller; R G Pestell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

10.  Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities.

Authors:  Rainer Loew; Elisa Vigna; Dirk Lindemann; Luigi Naldini; Herman Bujard
Journal:  J Mol Genet Med       Date:  2006-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.